-
1
-
-
1842530296
-
Causes and prevalence of visual impairment among adults in the United States
-
The Eye Diseases Prevalence Research Group. Causes and prevalence of visual impairment among adults in the United States. Arch Ophthalmol 2004; 122: 477–485.
-
(2004)
Arch Ophthalmol
, vol.122
, pp. 477-485
-
-
-
2
-
-
85007763600
-
Guide to Clinical Preventive Services
-
2nd edition Alexandria, Virginia International Medical Publishing
-
US Preventive Services Task Force. Guide to Clinical Preventive Services, 2nd edition. Chapter 34: Screening for Glaucoma. Alexandria, Virginia: International Medical Publishing, 1996.
-
(1996)
Chapter 34: Screening for Glaucoma
-
-
-
3
-
-
0036269833
-
The ocular hypertension treatment study: a randomized controlled trial determines that topical ocular hypotensive medication delays or prevents the onset of primary open-angle glaucoma
-
Kass MA, Heuer DK, Higginbotham EJ, Johnson CA, Keltner JL, Miller JP, et al. The ocular hypertension treatment study: a randomized controlled trial determines that topical ocular hypotensive medication delays or prevents the onset of primary open-angle glaucoma. Arch Ophthalmol 2002; 120: 701–713.
-
(2002)
Arch Ophthalmol
, vol.120
, pp. 701-713
-
-
Kass, M.A.1
Heuer, D.K.2
Higginbotham, E.J.3
Johnson, C.A.4
Keltner, J.L.5
Miller, J.P.6
-
4
-
-
0036822851
-
Reduction of intraocular pressure and glaucoma progression: results from the Early Manifest Glaucoma Trial
-
for the Early Manifest Glaucoma Trial Group
-
Heijl A, Leske MC, Bengtsson B, Hyman L, Bengtsson B, Hussein M for the Early Manifest Glaucoma Trial Group. Reduction of intraocular pressure and glaucoma progression: results from the Early Manifest Glaucoma Trial. Arch Ophthalmol 2002; 120: 1268–1279.
-
(2002)
Arch Ophthalmol
, vol.120
, pp. 1268-1279
-
-
Heijl, A.1
Leske, M.C.2
Bengtsson, B.3
Hyman, L.4
Bengtsson, B.5
Hussein, M.6
-
5
-
-
24944562844
-
Treatment and vision-related quality of life in the early manifest glaucoma trial
-
for the Early Manifest Glaucoma Trial Group in press, released online
-
Hyman LG, Komaroff E, Heijl A, Bengtsson B, Leske MC for the Early Manifest Glaucoma Trial Group. Treatment and vision-related quality of life in the early manifest glaucoma trial. Ophthalmology 2005;(in press, released online).
-
(2005)
Ophthalmology
-
-
Hyman, L.G.1
Komaroff, E.2
Heijl, A.3
Bengtsson, B.4
Leske, M.C.5
-
6
-
-
0029782854
-
Rate of progression in open-angle glaucoma from cross-sectional prevalence of visual field damage
-
Quigley HA, Tielsch JM, Katz J, Sommer A. Rate of progression in open-angle glaucoma from cross-sectional prevalence of visual field damage. Am J Ophthal 1996; 122: 355–363.
-
(1996)
Am J Ophthal
, vol.122
, pp. 355-363
-
-
Quigley, H.A.1
Tielsch, J.M.2
Katz, J.3
Sommer, A.4
-
7
-
-
0033498138
-
Proportion of those with open-angle glaucoma who become blind. Letter to the editor
-
Quigley HA. Proportion of those with open-angle glaucoma who become blind. Letter to the editor. Ophthalmology 1999; 106: 2039.
-
(1999)
Ophthalmology
, vol.106
, pp. 2039
-
-
Quigley, H.A.1
-
9
-
-
20144388203
-
Screening for glaucoma: recommendation statement
-
US Preventive Services Task Force. Screening for glaucoma: recommendation statement. Ann Fam Med 2005; 3: 171–172.
-
(2005)
Ann Fam Med
, vol.3
, pp. 171-172
-
-
-
10
-
-
16444375302
-
Screening for open-angle glaucoma in the primary care setting: an update for the US Preventive Services Task Force
-
Fleming C, Whitlock EP, Beil T, Smit B, Harris RP. Screening for open-angle glaucoma in the primary care setting: an update for the US Preventive Services Task Force. Ann Fam Med 2005; 3: 167–170.
-
(2005)
Ann Fam Med
, vol.3
, pp. 167-170
-
-
Fleming, C.1
Whitlock, E.P.2
Beil, T.3
Smit, B.4
Harris, R.P.5
|